Prognostic Markers

Incidental prostate cancer-prognostic factors. A population based-study from Orebro,Sweden with 20 years follow-up.

O Andren, Swen-Olof Andersson, Lennart Franzen and Jan-Erik Johansson.

Constitutive expression of MHC class II molecules in melanoma cell lines is due to a constitutive transcription of CIITA from its promoter III

V Deffrennes, J Vedrenne, PhD, MC Stolzenberg, PhD, G Barbieri, PhD, F Baton, J Piskurich, PhD, J Ting, PhD, D Charron, MD & PhD and C Alcaide-Loridan, PhD

Expressed gene clusters with distinct prognostic properties of primary breast tumors

K Iwao , R Matoba, PhD , S Noguchi, MD, PhD and K Kato, MD, PhD

Regulation of cancer cell proliferation and survival by β 1 integrins

M. Fornaro,PhD, Duo-Qi Zheng, MD PhD, Michela Manzotti, PhD,, Giovanni Tallini, MD, and Lucia R. Languino, PhD.

Expression of UGT2B7, a glucuronosyltransferase implicated in the inactivation of 4-hydroxyestrone, and in maintaining the activity of retinoic acid, is enhanced in human breast carcinoma in situ, but reduced or abrogated in invasive breast cancer.

J Weisz, M.B., B.Chir., SA Gesti, MS, DA Shearer, BA, EE Freuenhoffer, MD, G Clawson, MD, PhD, MD Green, MS, TR Tephly, MD, PhD

Realities of microsatellite instability in human cancer

S Oda,MD, Y Maehara,MD,PhD, K Sugimachi,MD,PhD

Phenotype modulation of tumor cell growth outlined by cell morphological patterns.

MAA Castro, MSc , F Klamt, MSc , G Schwartsmann, MD, PhD , I Grivicich, MSc , JCF Moreira, PhD .

A pathology sub-study of putative prognostic markers in colorectal cancer.

, Dr SA Grumett MD, Professor P Quirke MD PhD, Professor DJ Kerr MD PhD, Mr C McConkey PhD, Dr J Stahlsmidt MD, Dr J Barnwell PhD.

Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population.

ML Santos, Bsc, AS Sarkis,PhD, IN Nishimoto, Ms, MA Nagai, PhD

Salivary levels of NF-kappa B dependent cytokines of patients with oral squamous cell carcinoma

N.L. Rhodus, DMD, MPH, VU Ho,MD, C. S. Miller, DMD, MS, J. Burt,DMD, F. Ondrey, MD, PhD

Mutational alterations of connexin 43 associated with advanced stage of progression of human colon cancer

VA Krutovskikh, NA Iaitckil , DE Popov , SV Vasil'ev , MV Dubina

Prognostic value of the response to induction chemotherapy in patients with locally advanced inoperable urothelial cancer

JW de Beukelaar ,TA Splinter MD, PhD , CC vd Rijt MD, PhD , PI Schmitz PhD , WJ Kirkels MD, PhD

Genetic polymorphisms in the tumor necrosis factor (TNF) gene promoter influence non-Hodgkin's lymphoma outcome.

P Juszczynski, E Kalinka , G Salles, G Woszczek, M Borowiec, E Lech-Maranda, L Baseggio, M Kowalski, T Robak, B Coiffier, K Warzocha.

Telomerase expression in prostate cancer imprint smears of patients treated with radical prostatectomy

A. Bantis M.D. , P. Athanassiadou M.D., MIAC, M. Gonidi M.D., Ath Kyriakidis M.D., A. Liossi M.D., MIAC, E. Petrakakou M.D., P. Athanassiades M.D., A. Giannopoulos M.D.

Telomerase activity and Metallothionein expression in renal cell carcinomas

A.Ioakim-Liossi MD, MIAC, P.Athanassiadou MD, MIAC, D.Pantazopoulos MD, P.Karakitsos, MD, A.Karkabasi MD, D.Karandrea MD, E.Stergiou MD, E.Petrakakou MD, A.Giachnaki MD, P.Athanassiades MD

Low-density SNP chip for pharmacogenetic applications

S. Hauch, M. Lustig, M. Heisinger, S. Waschütza and E. Schnakenberg

Tumor-associated genes differentially expressed in breast tumors regarding the presence or absence of estrogen and progesterone receptors

MA Nagai, PhD, N Rós, Ms, EC Miracca, Ms, RLA Silva, Bsc, AF Carvalho, Ms FB Runza, Ms, LFL Reis, PhD MM Brentani, PhD,

Liver transplantation due to hepatocellular carcinoma: prognostic relevance of quantitative DNA ploidy

H. Al-Abadi, MD, T. Steinmueller, S. Jonas, I. Rotter, P. Neuhaus

A comprehensive investigation of D-Loop mutations in the mitochondrial DNA as potential diagnostic molecular markers for colorectal cancer.

SR Fradley, BSc Genetics

Osteopontin Expression may be induced by c-Src in Papillary Thyroid Carcinoma

Y Kato, PhD, H Zhu, MD,, R Tanaka, MD, T Obara, MD, K Sato, MD, T Sawada, MD, M Kobayashi, MD,

Rb and p16 expression characterizes two subgroups of gastrointestinal poorly differentiated endocrine carcinomas with different genetic alterations.

S Pizzi, PhD, T D'Adda, BScD, C Azzoni, PhD, D Bassi, L Bottarelli, BScD, M Milione, MD, C Bordi, MD

READ BY TITLE Immunosensors for determination of carcinoembryonic antigen by using solid-phase immunoassay

Huangxian Ju, Zong Dai, Jin Chen

Prognostic significance and clinical impact of the Thomsen-Friedenreich antigen in gastrointestinal cancer

U Karsten, PhD, Y Cao, MD, SE Baldus, MD, H Shigeoka, MD, G Butschak, PhD, A Kramer , S Goletz, PhD

Reliability assessment of soluble c-erbB-2 concentrations in the saliva of healthy women and men.

C Streckfus DDS, L Bigler, PhD, L Copeland DMD

Analysis of genetic abnormalities in locally advanced breast carcinomas determined by microsatellite alterations and p53 gene mutations

SF Picard, ST, N Franco, ST, L Hahnel, MS, M Arnal, MS, and S Lizard, PhD

Proteomic analysis of beta-catenin during the neoplastic progression from precursor lesions to invasive squamous cell carcinoma of the esophagus

MJ Roth, MD, N Hu, MD, CP Paweletz, MS, M Iwamoto, MD, Y-L Qiao, MD, W-J Li, MD, H. Su, PhD, DJ Ahnen, MD, SM Dawsey, MD, PR Taylor, MD,

Microsatellite instability in unselected Sardinian patients with endometrial cancer: screening for hMLH1/hMSH2 and PTEN germline mutations

P. Baldinu1, Ph.D., A. Cossu2, M.D., A. Manca1, Ph.D., M.P. Satta1, M. Pisano1, Ph.D., M. Casula1, Ph.D., S. Dessole3, M.D., A. Pintus2, M.D., F. Tanda2, M.D., and G. Palmieri1, M.D.

Transforming growth factor alpha: a valid surrogate endpoint biomarker?

SW Beenken, MD, RD Hockett Jr, MD, WF Malone, PhD, MPH, KI Bland, MD

Accurate detection and identification of Human Papillomavirus genotypes in archival cervical specimens by broad-spectrum PCR and reverse hybridization and the long-term risk identifies risk for development of cervical carcinoma.

W.G.V. Quint , Yolanda van der Graaf, Anco Molijn, Heleen Doornewaard, Bernhard Kleter, Leen-Jan van Doorn, Jan G. van den Tweel

Genetic polymorphisms in the the human leukocyte antigens (HLA DRB) loci and non-Hodgkin's lymphoma outcome.

E Kalinka, P Juszczynski , G Salles, G Woszczek, M Borowiec, E Lech-Maranda, L Baseggio, M Kowalski, T Robak, B Coiffier, K Warzocha.

Urinary tissue factor: A potential marker of malignant disease

Dr Bashir A. Lwaleed

TP53, MEK1, XIAP, BCL-2 and BAX as prognostic and predictive factors in ovarian carcinomas treated with platinum-based regimen.

J Kupryjanczyk, MD , T Szymanska, MD , R Madry, MD , G Karpinska, MD , A Rembiszewska, MSc , A Timorek, MD , I Ziolkowska, MD , J Stelmachow, MD , J Zielinski MD , J Markowska, MD